Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Convalescent plasma is "futile" as COVID-19 treatment for critically ill patients, trial shows

In the earliest days of the COVID-19 pandemic, the medical community turned to a century-old treatment: Take blood from recovered patients and give it to the sick.

4 Oct 2021

mRNA vaccination induces strong humoral immune responses against SARS-CoV-2 in over 80's

A recent study assesses the serological and cellular responses to Pfizer’s BNT162b2 mRNA vaccine in people aged 80-96 years.

4 Oct 2021

Health-related quality of life of COVID-19 patients with long-COVID: Study

Researchers conducted a survey-based study and assessed the impact of long COVID on the health-related quality of life in Japanese COVID-19 patients.

4 Oct 2021

Using nasopharyngeal microbiota as early biomarker in patients with COVID-19

A new study aimed to analyze the nasopharyngeal microbiota of patients who were hospitalized with COVID-19.

4 Oct 2021

Mandatory vaccines for health care workers might upend nurses’ training

Kaitlyn Hevner expects to complete a 15-month accelerated nursing program at the University of North Florida in Jacksonville in December. For her clinical training this fall, she's working 12-hour shifts on weekends with medical-surgical patients at a hospital.

4 Oct 2021

SARS-CoV-2 infection and severity are strongly associated with nasal microbiota

In a recent study, researchers conducted a nasopharyngeal microbiota profiling parallelism in an effort to analyze microbiota variations in COVID-19 patients.

3 Oct 2021

Important factors that determine the child clinical COVID-19 attack ratio

A new modeling study aimed to determine the attack ratio among children between the ages of 0-11 years in Ontario, Canada.

3 Oct 2021

Researchers discover six ways in which COVID-19 risk perception was expressed by the public

Recognizing the widespread use of Twitter as a mainstream news source for the American public, UCI researchers sought to investigate how tweets about masks expressed COVID-19 risk perceptions in the first five months of the pandemic.

3 Oct 2021

COVID-19 may trigger hyperglycemia by disrupting key metabolic signals to cause severe disease

COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

2 Oct 2021

CDC awards $15.88 million to Wayne State University to study viral infection surveillance

The U.S. Centers for Disease Control and Prevention has awarded $15.88 million to the Wayne State University School of Medicine's Department of Emergency Medicine to be the epicenter of a national study on viral infections that present in emergency departments across the county.

1 Oct 2021

EKF Diagnostics appoints Luke Daum as Chief Scientific Officer

EKF Diagnostics, the global in vitro diagnostics company, has appointed Luke Daum PhD as Chief Scientific Officer, bringing a wealth of expertise in molecular-based diagnostics to EKF’s leadership team.

From EKF Diagnostics 1 Oct 2021

Researchers develop nanoparticles delivering STING agonists for intravenous cancer immunotherapy

Cancer immunotherapy seeks to turn "cold" tumors into "hot" tumors––those that respond to immunotherapy––by awakening and enlisting the body's own immune system.

30 Sep 2021

Early-stage interaction of monocytes with SARS-CoV-2-infected epithelial cell decides COVID-19 severity

A team of scientists from the USA and France has recently unveiled the mechanism of immune dysregulation in coronavirus disease 2019 (COVID-19) patients by analyzing the early-stage interaction between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected epithelial cells and immune cells. The study is currently available on the bioRxiv* preprint server.

30 Sep 2021

Government sets additional funding for infection prevention and control in social care settings

People who receive care and the adult social care workforce will be further protected from COVID-19 and flu over the coming months, as the government sets additional funding for infection prevention and control.

30 Sep 2021

Study investigates long-COVID symptoms in people recovering from COVID-19 infection

This new study from the University of Oxford and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC) investigated long-COVID in over 270,000 people recovering from COVID-19 infection, using data from the US-based TriNetX electronic health record network.

30 Sep 2021

The applications of nanomaterials against viral disease

Large-scale SARS-CoV-2 spike protein mutants analysis identifies subclonal variants indicative of within-host viral diversity

Researchers have investigated a vast SARS-CoV-2 assembly and NGS data set to detect non-synonymous S protein mutations.

29 Sep 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Convalescent plasma is "futile" as COVID-19 treatment for critically ill patients, trial shows

mRNA vaccination induces strong humoral immune responses against SARS-CoV-2 in over 80's

Health-related quality of life of COVID-19 patients with long-COVID: Study

Using nasopharyngeal microbiota as early biomarker in patients with COVID-19

Mandatory vaccines for health care workers might upend nurses’ training

SARS-CoV-2 infection and severity are strongly associated with nasal microbiota

Important factors that determine the child clinical COVID-19 attack ratio

Researchers discover six ways in which COVID-19 risk perception was expressed by the public

COVID-19 may trigger hyperglycemia by disrupting key metabolic signals to cause severe disease

CDC awards $15.88 million to Wayne State University to study viral infection surveillance

EKF Diagnostics appoints Luke Daum as Chief Scientific Officer

Researchers develop nanoparticles delivering STING agonists for intravenous cancer immunotherapy

Early-stage interaction of monocytes with SARS-CoV-2-infected epithelial cell decides COVID-19 severity

Government sets additional funding for infection prevention and control in social care settings

Study investigates long-COVID symptoms in people recovering from COVID-19 infection

The applications of nanomaterials against viral disease

Scientists describe SARS-CoV-2 uptake in tissue-resident human macrophages enhanced by virus-specific antibodies

Effect of biologic therapy on COVID-19 in children suffering from rheumatic diseases

Immunocompromised patients show decreased response to SARS-CoV-2 mRNA vaccines

Large-scale SARS-CoV-2 spike protein mutants analysis identifies subclonal variants indicative of within-host viral diversity

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Newsletters you may be interested in